Liberum acts as Nominated Adviser & Sole Bookrunner on the £29 million fundraise for Science in Sport plc
Liberum is pleased to announce that it acted as Financial Adviser, Nominated Adviser and Sole Bookrunner in relation to a placing & acquisition by Science in Sport plc, raising £29 million. The placing part funded the acquisition of PhD Nutrition Ltd for a total consideration of £32 million.
Science in Sport plc, a UK-headquartered market leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts.
PhD is a UK-headquartered premium protein brand, which has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.
The deal doubles the size of the Company and accelerates their ambition to become a global leader in premium performance nutrition. SIS and PhD are two businesses that have complementary brands, products, operations and sales channels which together create a well-balanced, cash generative company with enhanced potential.
Liberum Team
Investment Banking – Clayton Bush, Chris Clarke, James Greenwood, William Hall, Stephanie Poulier
Sales – Oliver Baxendale, Julian Collett, Gerard O’Doherty, Sebastian Fernandez
Research – Wayne Brown, Tom Musson
Corporate Access – Marcio Remedios
Twitter: @LiberumToday
LinkedIn: Liberum
